Information:
Fel:
ID
31861
Beskrivning
A Study for Patients With Active Rheumatoid Arthritis Despite Ongoing Methotrexate Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT00785928
Länk
https://clinicaltrials.gov/show/NCT00785928
Nyckelord
Versioner (1)
- 2018-10-04 2018-10-04 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
4 oktober 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Rheumatoid Arthritis NCT00785928
Eligibility Rheumatoid Arthritis NCT00785928
- StudyEvent: Eligibility
Similar models
Eligibility Rheumatoid Arthritis NCT00785928
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Informed Consent
Item
have given written informed consent
boolean
C0021430 (UMLS CUI [1])
Gender | Risk Absent Pregnancy
Item
women must not be at risk to become pregnant during study participation
boolean
C0079399 (UMLS CUI [1])
C0035647 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0032961 (UMLS CUI [2,3])
C0035647 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0032961 (UMLS CUI [2,3])
Rheumatoid Arthritis
Item
diagnosis of rheumatoid arthritis
boolean
C0003873 (UMLS CUI [1])
Methotrexate Dose Stable
Item
current, regular use of methotrexate, at a stable dose
boolean
C0025677 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
Inclusion criteria Research Personnel
Item
other criteria to be reviewed by study doctor
boolean
C1512693 (UMLS CUI [1,1])
C0035173 (UMLS CUI [1,2])
C0035173 (UMLS CUI [1,2])
Pharmaceutical Preparations Excluded
Item
use of excluded medications(reviewed by study doctor)
boolean
C0013227 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0332196 (UMLS CUI [1,2])
TNF-alpha blockers Successful treatment
Item
have not failed biologic tnfa inhibitor therapy
boolean
C2170827 (UMLS CUI [1,1])
C0521982 (UMLS CUI [1,2])
C0521982 (UMLS CUI [1,2])
Communicable Disease Study Subject Participation Status At risk
Item
have had recent or ongoing infection which, in the opinion of the study doctor put patient at an unacceptable risk for participation in the study
boolean
C0009450 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C1444641 (UMLS CUI [1,3])
C2348568 (UMLS CUI [1,2])
C1444641 (UMLS CUI [1,3])
Tuberculosis
Item
evidence of tuberculosis
boolean
C0041296 (UMLS CUI [1])
SYSTEMIC INFLAMMATORY PROCESS | Exception Rheumatoid Arthritis | Juvenile rheumatoid arthritis | Crohn Disease | Ulcerative Colitis | Arthritis, Psoriatic | Spondylarthropathy Seronegative
Item
have systemic inflammatory condition other than ra, such as juvenile ra, crohn's disease, ulcerative colitis, psoriatic arthritis or seronegative spondyloarthropathy
boolean
C0749224 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0003873 (UMLS CUI [2,2])
C3714757 (UMLS CUI [3])
C0010346 (UMLS CUI [4])
C0009324 (UMLS CUI [5])
C0003872 (UMLS CUI [6])
C0949691 (UMLS CUI [7,1])
C0521144 (UMLS CUI [7,2])
C1705847 (UMLS CUI [2,1])
C0003873 (UMLS CUI [2,2])
C3714757 (UMLS CUI [3])
C0010346 (UMLS CUI [4])
C0009324 (UMLS CUI [5])
C0003872 (UMLS CUI [6])
C0949691 (UMLS CUI [7,1])
C0521144 (UMLS CUI [7,2])
Exclusion Criteria Research Personnel
Item
other criteria to be reviewed by study doctor
boolean
C0680251 (UMLS CUI [1,1])
C0035173 (UMLS CUI [1,2])
C0035173 (UMLS CUI [1,2])